Your browser doesn't support javascript.
loading
Fluoxetine oral treatment discloses 5-HT1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat.
López, Cristina; Gómez-Roso, Miriam; García-Pedraza, José Ángel; Martín, María Luisa; Morán, Asunción; García-Domingo, Mónica.
Affiliation
  • López C; a Laboratory of Pharmacology, Department of Physiology and Pharmacology, Faculty of Pharmacy, University of Salamanca, 37007, Salamanca, Spain.
  • Gómez-Roso M; a Laboratory of Pharmacology, Department of Physiology and Pharmacology, Faculty of Pharmacy, University of Salamanca, 37007, Salamanca, Spain.
  • García-Pedraza JÁ; b Research Institute of Salamanca (IBSAL), Paseo San Vicente 58-182, 37007, Salamanca, Spain.
  • Martín ML; a Laboratory of Pharmacology, Department of Physiology and Pharmacology, Faculty of Pharmacy, University of Salamanca, 37007, Salamanca, Spain.
  • Morán A; a Laboratory of Pharmacology, Department of Physiology and Pharmacology, Faculty of Pharmacy, University of Salamanca, 37007, Salamanca, Spain.
  • García-Domingo M; b Research Institute of Salamanca (IBSAL), Paseo San Vicente 58-182, 37007, Salamanca, Spain.
Can J Physiol Pharmacol ; 97(2): 90-98, 2019 Feb.
Article in En | MEDLINE | ID: mdl-30462556
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vagus Nerve / Bradycardia / Fluoxetine / Antidepressive Agents, Second-Generation / Receptor, Serotonin, 5-HT1D Type of study: Etiology_studies Limits: Animals / Humans Language: En Journal: Can J Physiol Pharmacol Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vagus Nerve / Bradycardia / Fluoxetine / Antidepressive Agents, Second-Generation / Receptor, Serotonin, 5-HT1D Type of study: Etiology_studies Limits: Animals / Humans Language: En Journal: Can J Physiol Pharmacol Year: 2019 Document type: Article